The name of the healthcare offspring of Amazon, Berkshire Hathaway, and JPMorgan Chase is finally here.
After more than a year of gestation, the name of the healthcare offspring of Amazon, Berkshire Hathaway, and JPMorgan Chase is finally here.
Haven.
The separate, independent company, plans for which were announced early last year, launched a website Wednesday, and on it, it explained why it chose the name Haven.
“It reflects our goal to be a partner to individuals and families and help them get the care they need, while also working with clinicians and others to make the overall system better for all,” the new firm stated.
It also said that for now, the nonprofit company will benefit employees of the 3 firms, and over time, it will share what it’s found with others. Chiefly, it aims to combine what it called “common-sense fixes” with innovation to make prescription drugs more affordable, improve access to primary care, and simplify the fine-print minutiae of insurance benefits. And, as it said in its original announcement, it wants to use data and technology to improve healthcare overall.
“We will be an ally of anyone who is working to make health care better for patients,” the company said.
The nonprofit status means that Haven “will reinvest any surplus back into our work to improve health outcomes, patient satisfaction, and lower costs for individuals and families,” the company said.
In a letter on the website, chief executive officer (CEO) Atul Gawande, MD, MPH, said that the new firm would be “relentless” in pursuing solutions and noted that it was formed because the 3 founding companies “have been frustrated by the quality, service, and high costs that their employees and families have experienced in the US health system.”
In January 2018, the 3 companies announced in a joint statement that they planned on forming a separate, independent company “free from profit-making incentives and constraints” to tackle the issue of rising healthcare costs for employees and their families.
Haven is headquartered in Boston and also has an office in New York. The board is made up of 3 members of the founding companies—Todd Combs, an investment officer of Berkshire Hathaway; Jamie Dimon, chairman and CEO of JPMorgan Chase; and Beth Galetti, a senior vice president at Amazon—and Gawande.
Gawande was named to the top spot last June.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More